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http://www.biomedcentral.com/1471-2318/13/60RESEARCH ARTICLE Open AccessDepression following hip fracture is associated
with increased physical frailty in older adults: the
role of the cortisol: dehydroepiandrosterone
sulphate ratio
Anna C Phillips1,3*, Jane Upton1,3, Niharika Arora Duggal2,3, Douglas Carroll1 and Janet M Lord2,3Abstract
Background: Hip fracture in older adults is associated with depression and frailty. This study examined the
synergistic effects of depression and hip fracture on physical frailty, and the mediating role of the cortisol:
dehydroepiandrosterone sulphate (DHEAS) ratio.
Methods: This was an observational longitudinal study of patients with a hip fracture carried out in a hospital
setting and with follow up in the community.
Participants were 101 patients aged 60+ years (81 female) with a fractured neck of femur.
Measurements of the ability to carry out activities of daily living (ADL), cognitive function, physical frailty and assays
for serum cortisol and DHEAS were performed six weeks and six months post-hip fracture. Depressed and
non-depressed groups were compared by ANOVA at each time point.
Results: Hip fracture patients who developed depression by week six (n = 38) had significantly poorer scores on
ADL and walking indices of frailty at both week six and month six, and poorer balance at week six. The association
with slower walking speed was mediated by a higher cortisol:DHEAS ratio in the depressed group.
Conclusion: Depression following hip fracture is associated with greater physical frailty and poorer long term
recovery post-injury. Our data indicate that the underlying mechanisms may include an increased cortisol:DHEAS
ratio and suggest that correcting this ratio for example with DHEA supplementation could benefit this patient
population.
Keywords: Depression, Hip fracture, Frailty, Cortisol, Dehydroepiandrosterone sulphateBackground
With the ageing of the population, hip fractures are a
growing issue, with UK rates predicted to increase to
117,000 per annum by 2016 [1]. At least half of hip frac-
ture patients never regain their previous function [2], and
post-hip fracture mortality at one year has been recorded
as high as 33% [3]. The factors influencing recovery from
hip fracture are poorly understood although depression is
a common co-morbidity in these patients [4].* Correspondence: A.C.Phillips@bham.ac.uk
1School of Sport and Exercise Sciences, University of Birmingham,
Birmingham B15 2TT, UK
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© 2013 Phillips et al.; licensee BioMed Central
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reproduction in any medium, provided the orThe prevalence rate for depression in hip fracture
patients across eight US and UK studies ranged from
9–47% [5]. However, most previous research has included
patients with depression prior to hip fracture, so the health
consequences of new onset depression, i.e., depression oc-
curring shortly after hip fracture and most likely attribut-
able to this traumatic event, are unclear. Depression may
affect the recovery of walking independence [6], as well as
being associated with poorer rehabilitation participation [7],
increased risk of falling again [8], increased susceptibility to
infectious disease and higher mortality rates [4]. Depression
coincident with the physical trauma of hip fracture may
therefore accelerate progression from health to frailty. Un-
derstanding the mechanisms mediating the link betweenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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may reveal novel approaches to improving recovery.
Cortisol levels are often higher in individuals with
depression [9,10]. A reduction in physical function may
also be driven by age-related increases in the ratio be-
tween cortisol and the anti-glucocorticoid dehydroepian-
drosterone sulphate (DHEAS). Higher cortisol levels in
older adults have been associated with characteristics of
frailty including a reduction in grip strength over a six
year period [11] and standing and walking performance
[12]. Low levels of serum DHEAS have been associated
with poorer physical function [13]. Importantly, the
cortisol:DHEAS ratio is higher in older hip fracture pa-
tients than in healthy controls [14] or younger compar-
able fracture patients [15]. Adrenocortical hormone
balance may thus be a major determinant of frailty in
older hip fracture patients, particularly in those with
depression. However, the combined effects of both hip
fracture and depression in the context of potential
mechanisms for frailty outcomes have not been exam-
ined until now. The present analysis sought to examine
the associations between post-hip fracture depression, in
patients without a prior diagnosis and history of depression
before age 50 years, and physical frailty in older adults, and
the potential role of cortisol and DHEAS.
Methods
Participants
Participants were 101 older adults (81 female) with a
mean ± SD age of 83.9 ±7.88 years who were admitted
to hospital in-patients with a fractured neck of femur
(hip fracture). Participating hospitals were all located
in the West Midlands, UK. Inclusion criteria were that
patients had sustained a hip fracture, were 60+ years of
age and did not meet the exclusion criteria. The latter
included existing medical conditions or medications
that could affect the immune system (e.g. glucocorticoids
and immune suppressants), dementia, taking antidepres-
sants or having a previous diagnosis of depression before
the age of 50 years. In this way we aimed to recruit those
patients who had likely developed depression post-fracture,
rather than those who already had a history of depression.
We were thus focusing on those with a first or new epi-
sode of depressive symptoms evident post-fracture, and
most likely resulting from the trauma of hip fracture.
All participants were Caucasian. All participants gave
written informed consent prior to the study, which was ap-
proved by South Staffordshire Research Ethics Committee
(study ref: 09/H1203/80).
Study design and procedure
The study was a longitudinal investigation comparing
the physical frailty and cognitive function of depressed
and non-depressed older hip fracture patients 6 weeksand 6 months post fracture. Participants completed a ques-
tionnaire pack and undertook a range of measures to assess
physical frailty. Socio-demographics and health behaviours
were recorded to assess for bias between the non-depressed
and depressed groups. Participants also provided a blood
sample in order to determine serum concentrations of
cortisol and DHEAS.
Questionnaires and frailty measures
The Geriatric Depression Scale (GDS) was specifically
developed to screen the older population for depression
[16]. A shorter version, the 15-item GDS (GDS-15) is
widely used and explores dimensions of mood such as
self-esteem, distressing thoughts, positive attitude toward
life and judgment about own condition over the previous
week. Respondents answer yes or no to each item; scores
range from 0 to 15. A score of six or above was used to cat-
egorise patients as ‘depressed’ [17]. The commonly used
reliable and valid Hospital Anxiety and Depression Scale
(HADS) [18] was used to confirm depression symptoms
on a 7-item five-point scale (0–4) [19].
The Oxford Hip Score [20] (OHS) is a 12-item question-
naire validated to assess activities of daily living (ADL) and
ability in patients undergoing hip replacement surgery.
Each item has 5 possible responses with scores ranging
from 0–4, with 4 being the best outcome. Although not
validated for use with hip fracture, the Cronbach’s alpha at
week 6 in the present study was 0.84.
Physical frailty was assessed in part via the OHS but in
addition upper body strength was measured as handgrip
strength using a hydraulic hand dynamometer, lower
body strength using the Timed Up and Go (TUG) test
[21] and the Berg Balance Scale (BBS) [22]. The BBS
comprises 14 observable tasks to assess balance statically
and during the performance of tasks. It is a reliable and
valid scale with published norms by gender and decade
of age [23].
Data gathered included: date of birth, if suffering from
chronic illness or taking ongoing medication, and occu-
pational category of the previous main bread winner
using the Registrar General’s classification of occupa-
tions [24]. Occupational status was grouped as manual
or non-manual. Body mass index (BMI) was computed
as kg/m2 from measured height and weight. Health
behaviours were recorded using a questionnaire adapted
from the Whitehall study [25]. The time frame was over
the past year at week 6 and since their hip fracture at
month 6. Participants indicated their levels of physical
activity, cigarette smoking, alcohol consumption, and
sleep length using a simple categorical scoring system.
With the exception of physical activity, which was calcu-
lated as a weighted score (vigorous exercise × 3 +moderate
exercise × 2 +mild exercise), these were then converted into
binary variables splitting at the median.
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A venous blood sample was taken from each participant
between the hours of 0800–1130 am at week 6 and month
6. Serum cortisol and DHEAS were analysed in duplicate
using separate ELISA based assays and commercial kits
(IBL International, Hamburg, Germany). Intra-assay coeffi-
cients were < 10%.
Data analysis
Differences between the depressed and non-depressed
group on the main demographic, health behaviour, and
operation-related variables were tested using chi-square
and ANOVA. In order to examine group differences at
week 6 and month 6 in the key psychosocial and frailty
variables, ANOVA was used. Repeated measures ANOVA
and ANCOVA models were run to assess changes in these
variables between the two sampling times, and whether
trajectory of change was influenced by depression status,
respectively. Any socio-demographics or health behav-
iours which significantly differed between the groups were
included as covariates to control for confounding. Week 6
health behaviours were included in analyses predicting
week 6 outcomes, and month 6 behaviours for month 6
outcomes. Regression was used to examine the associa-
tions between the cortisol: DHEAS ratio and the outcome
variables. Where hormone levels were associated with
frailty, potential mediation by cortisol: DHEAS was tested
by entering depression group at step 1, and cortisol:
DHEAS ratio at step 2, and confirmed by Sobel test.
Moderation was tested where cortisol:DHEAS was related
to depression group but not the outcome variables. Mean-
centred variables and interaction terms were created and
regressions run with the mean-centred variables entered
at step 1, and interaction term at step 2.
Results
Recruitment and withdrawal data are shown in Figure 1,
including two individuals who were later found to violate
the inclusion criteria and thus were not included in ana-
lyses. Ineligibility was mainly due to the stringent inclusion
criteria we had set in order to be able to meaningfully
assess the impact of stress on immune function. Main rea-
sons for declining to participate were feeling too ill to want
to undergo the procedures, which were time consuming
and demanding. Other reasons mainly consisted of loss to
follow-up in the time between identification via the hospital
patient database and consenting. This was due to Ethics
committee procedures requiring 48 hours minimum deci-
sion time from receiving information until consent. Conse-
quently, during this time many patients were discharged, or
moved to other wards or facilities and were unable to be
traced anonymously from their original admission records.
Drop-out post-consent but prior to testing at six weeks
(N = 97) was most commonly due to a change of mind bythe patient or family members. From the minimal informa-
tion available at this stage we are able to confirm that there
was no age (p = .68) gender (p = .15) or hospital recruitment
site (p = .36) bias between those who consented then with-
drew and those who remained in the study for the six week
testing session. Reasons for withdrawal between week 6
and month 6 included: death or being too unwell to be
tested (N = 17), not being able to continue in the study for
a variety of reasons including feeling they had too much to
cope with, now receiving treatment for depressive symp-
toms or other medication/illnesses on the list of exclusion
criteria, or being non-contactable (N = 18). Again, there
was little evidence of selection bias between the sample
who withdrew or remained in the study at six months in
terms of gender (p = .26), initial depression group status
(p = .72), BMI (p = .34), number of medications being
taken (p = .09), and hospital recruited at (p = .26). However,
those who withdrew were marginally more likely to be
from the manual occupational group, (p = .05), were, on
average, 3.9 years older (p = .02), and had 0.5 more
comorbidities on average (p = .03).
Demographics and health behaviour
Detailed demographics and health behaviour of the two
hip fracture groups (depressed or non-depressed) are
shown in Table 1. The groups were comparable on all of
the key variables. About half (48.5%) were from manual
occupational households, and mean BMI was in the nor-
mal range. One third (38, 37.6%) were classified as having
significant depressive symptoms at week 6 using the GDS-
15. At month 6, data were available for 66 participants; 19
(29%) of whom were depressed. Any participant originally
eligible for the study but later started on anti-depressants
or therapy for depression post-six week assessment was
excluded from the six month assessment.
Psychosocial factors
Mean (SD) for psychosocial variables are reported in
Table 2. Participants classified as depressed had significantly
higher GDS scores by an average of 5.6, F(1,99) = 197.02,
p < .001, η2 = .666, at week 6. At month 6, this difference
remained significant, F(1,64) = 30.10, p < .001, η2 = .320;
those who were classified as depressed at week 6 still had
significantly higher depression scores at month 6, with a
mean group difference of 3.9. There was no detectable
change in GDS depression score between week 6 and
month 6. However, six of the non-depressed patients
became depressed, as classified by the GDS at month 6,
and 11 of the depressed patients became non-depressed, χ2
(1) = 11.85, p = .001. The main analysis by group will focus
on participants’ depression classification at week 6 in order
to examine the effect of a first or new episode of depressive
symptoms evident post-fracture, and likely resulting from
the hip fracture and its consequences. The difference in
Figure 1 Consort diagram showing recruitment rates.
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firmed by significant group differences on the HADS
depression sub-scale, at week 6, F(1,98) = 65.02, p < .001,
η2 = .399, and month 6, F(1,64) = 19.46, p < .001, η2 = .233.
Frailty measures
Physical frailty was assessed using four measures. As shown
in Table 2, depressed patients were less able to engage inADL than non-depressed patients at week 6, F(1,72) = 13.87,
p < .001, η2 = .161, and month 6, F(1,57) = 6.22, p = .02,
η2 = .098. ADL significantly improved over time, F(1,46) =
15.97, p < .001, η2 = .258, although this did not vary by
depression group.
At both time points, depressed and non-depressed pa-
tients did not significantly differ in hand grip strength.
Overall, hand grip strength declined over time among
Table 1 Demographic characteristics, testing details and health behaviours
Depressed at Week 6 Not Depressed at Week 6
Mean (Standard Deviation) / Number (%) p
Week 6:
Number in group = 101 38 (38) 63 (62)
Age (years) 84.0 (8.62) 83.8 (7.48) .92
Sex (Male) 7 (18.4) 13 (20.6) .79
Body Mass Index (kg/m2) 22.6 (4.05) 23.5 (3.88) .31
Days between hip fracture and Week 6 interview 42.6 (14.06) 42.8 (12.81) .94
Days since hip fracture and Month 6 interview 189.6 (17.58) 195.6 (12.09) .15
Number of withdrawals (not including deaths) 11 (29) 19 (30.2) .72
Deceased within 6 months 3 (8) 2 (3) .29
Type of fracture (intracapsular) 20 (59) 37 (63) .71
Occupational status (Manual) 21 (55.3) 28 (44.4) .21
Number of co-morbidities 2.2 (1.41) 2.0 (1.28) .40
Number of medications 5.3 (2.96) 4.6 (2.68) .23
Taking pain medication 26 (68) 44 (70) .88
Exercise score (out of maximum of 30) 9.9 (3.63) 10.1 (3.32) .16
Less than 8 hours sleep per night 19 (50.0) 28 (44.4) .59
Alcohol (>1 drink per month) 15 (39.5) 22 (34.9) .65
One or more cigarettes per day 6 (15.8) 7 (11.1) .50
Month 6: Number in group = 66
Depressed at Month 6 13 (54) 6 (14)
Not Depressed at Month 6 11 (46) 36 (86)
Exercise score (out of maximum of 30) 8.8 (2.34) 8.9 (3.80) .92
Less than 8 hours sleep per night 16 (66.7) 27 (67.5) .95
Alcohol (>1 drink per month) 9 (37.5) 19 (46.3) .49
One or more cigarettes per day 3 (12.5) 4 (9.8) .73
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η2 = .099, but this deterioration was not influenced by
depression status. However, those with depression took
significantly longer to complete the TUG test at week
6, F(1,82) = 4.16, p = .05, η2 = .048, and at month 6,
F(1,54) = 3.90, p = .05, η2 = .067, compared to the non-
depressed group. Both groups were far slower than age-
related norms at both time-points. Walking speed (TUG)
improved over time overall, F(1,51) = 14.47, p < .001,
η2 = .221. Depressed patients also scored significantly
worse on the Berg Balance scale at week 6, F(1,78) = 8.35,
p = .005, η2 = .097, compared to the non-depressed.
However, there was no significant difference by month 6.
Balance also improved over the 6 month period, F(1,46) =
28.71, p < .001, η2 = .384, in both groups.
Potential mediation by cortisol:DHEAS ratio difference
As shown in Figure 2 the serum cortisol:DHEAS ratio at
week 6 differed significantly between the groups, with
depressed participants having a higher ratio than thenon-depressed, F(1, 95) = 7.26, p = .008, η2 = .071. This
difference remained significant at month 6, F(1, 52) = 5.75,
p = .02, η2 = .100. There was no significant change in the
cortisol:DHEAS ratio from week 6 to month 6 in either
group. Cortisol:DHEAS at week 6 was not associated with
the OHS or balance score at either time point or the TUG
at week 6. However, it was significantly positively related
to TUG test time at month 6, such that the higher the
cortisol:DHEAS ratio, the longer it took the participant to
walk three metres, β = .44, p = .001, ΔR2 = .20. Cortisol:
DHEAS at month 6 was not associated with the month 6
scores for OHS or balance score. However, it was again
positively related to TUG test time at month 6, such that
the higher the cortisol:DHEAS ratio at month 6, the
longer it took the participant to walk three metres β = .39,
p = .008, ΔR2 = .15.
When the regression predicting walking speed (TUG) at
month 6 from depression group was rerun with adjustment
for week 6 cortisol:DHEAS ratio, the association with
depression group became non-significant, with evidence
Table 2 Psychosocial and frailty measures by hip fracture group
Depressed Not Depressed
Mean (Standard Deviation) / Number (%) p
Week 6: Number = 101
Number in group 38 (38) 63 (62)
Geriatric Depression Scale 8.2 (2.47) 2.6 (1.53) <.001
Hospital Anxiety and Depression Scale Depression 9.1 (4.71) 3.4 (2.31) <.001
Hospital Anxiety and Depression Scale Anxiety 8.0 (4.55) 4.0 (3.71) <.001
Oxford Hip Score 22.1 (9.33) 30.0 (8.04) <.001
Mini Mental State Examination Score 24.4 (4.08) 24.7 (4.60) .78
Hand Grip Mean (kg) 14.3 (6.20) 15.9 (6.69) .25
Timed-Up-and-Go (seconds) 69.6 (47.03) 52.4 (30.31) .04
Berg Balance Scale Score 17.6 (14.80) 27.4 (14.16) .005
Month 6: Number = 66
Depressed 19 (29) 47 (71)
Geriatric Depression Scale 7.0 (3.75) 3.1 (1.99) <.001
Hospital Anxiety and Depression Scale Depression 7.6 (4.21) 4.0 (2.57) <.001
Hospital Anxiety and Depression Scale Anxiety 7.0 (5.07) 3.5 (3.01) .001
Oxford Hip Score 29.6 (8.97) 35.3 (8.14) .02
Mini Mental State Examination 25.3 (3.89) 25.9 (3.59) .51
Hand Grip Mean (kg) 14.2 (6.7) 16.3 (6.56) .25
Timed-Up-and-Go (seconds) 50.8 (36.23) 34.4 (25.81) .05
Berg Balance Scale Score 32.7 (13.4) 36.1 (12.71) .37
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such that a higher cortisol:DHEAS ratio explained the rela-
tionship between depression group and longer TUG speed.
There was also significant mediation by the cortisol:DHEAS
ratio at month 6, p = .04. The regression equation steps
with and without adjustment for cortisol:DHEAS are
shown in Figure 3 to illustrate the mediation.Figure 2 Serum cortisol and DHEAS were measured at 6 weeks
and 6 months post fracture and their ratio determined. The data are
the mean (±SE) for the cortisol:DHEAS ratio for hip fracture patients by
depression group at 6 weeks and 6 months post fracture.Potential moderation by cortisol:DHEAS
Cortisol:DHEAS at week 6 was not associated with the
OHS, balance score, TUG at week 6. However, to test
for moderation effects an interaction term was created
from the mean-centred variables. When regressions were
run predicting each frailty outcome separately with
depression group and cortisol:DHEAS entered at step 1,
and the relevant interaction term at step 2, there was no
significant cortisol:DHEAS at week 6 × depression inter-
action effect for the TUG, BBS, or OHS at week 6. This
suggests no moderation by cortisol:DHEA of the associ-
ation between depression and these frailty outcomes at
week 6. Cortisol:DHEAS at month 6 was not associated
with the month 6 scores for OHS or BBS score. Regressions
using the mean-centred interaction term showed no sig-
nificant month 6 cortisol:DHEAS × depression interaction
effects for BBS or OHS at month 6, suggesting no evidence
of moderation.
Discussion
In the current study, depression post-hip fracture was
associated with poorer ADL and slower walking speed
six weeks and six months post-hip fracture. Depressed
participants also had significantly poorer physical func-
tioning, as reflected in lower Berg Balance scale scores
at week 6. These group differences were not driven by
Figure 3 Mediation analyses. Values represent standardized β coefficients. * = p < .05.
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cortisol:DHEAS ratio differed between the groups at
both time points and mediated the relationship between
depression and slow walking speed at month 6.
The incidence rates for depression in our study are
higher than a previous report showing 17% of patients
had new-onset depression at 6 weeks post hip fracture
[9]. The much higher incidence of depression post-fracture
found here may reflect that co-morbidities were relatively
low in our sample and thus injury and loss of independence
may have had a greater impact on wellbeing. This requires
further investigation given the considerable impact of de-
pression on patients’ quality of life as well as on hip fracture
outcomes [26].
Regarding physical frailty, a detrimental effect of de-
pression on ADL has been reported previously in those
with or without prior depression [27]. In the present
study we found that this relationship was still present at
6 months post-hip fracture. As self-reported ADL may
be affected by depressive symptomatology [27], objective
levels of physical function were also measured. The
detrimental impact of post hip fracture depression on
walking speed reported here is in accordance with most
previous studies [28] with one exception, in which
depressive symptomatology was not predictive of walking
ability at one-year post discharge [29]. This contrast withthe present results may reflect differences in the timing
and type of measurement; we assessed depression at
6 weeks post-fracture predicting TUG at 6 weeks and
6 months, whereas this previous study was examining pre-
dictors of walking ability at one year, and walking ability
was not directly assessed but rated over the telephone.
This study included a measure of dynamic balance
which differed between the depression groups at week 6
but not at month 6. In contrast, it has been reported
previously that depression can have a detrimental effect
on physical function at 12 months [28], although this
effect was very small. The mean balance score for both
groups at 6 months was lower than that reported for
community dwelling older adults [29], although it was
similar to that reported for institutionalised older adults
[30]. This suggests that hip fracture severely impaired
balance, but given improvements, institutionalisation is
not necessarily a consequence.
That the week 6 cortisol:DHEAS ratio was higher
among the depressed hip fracture group is supported by
previous studies [14]. In the present study, the ratio was
also associated with poorer physical function, and mediated
the association between depression and walking speed at
month 6. This underlines the previously reported associa-
tions between higher cortisol, lower DHEAS and physical
frailty [12,13] and is likely to be due to the effects of high
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reduction in bone density [32]. It is possible to argue that
the cortisol:DHEAS ratio could, however, be acting as a
confounder in the depression-frailty association rather
than a mediator, as it is expected that the trauma of hip
fracture would contribute to an increased cortisol:DHEAS
ratio which could then underlie both depressive symptoms
and frailty in terms of walking speed. However, analyses
conducted as part of a parallel manuscript has confirmed
that the cortisol:DHEAS ratio only significantly differed
between those patients with depression and those without
(p = .004) and controls (p = .001), but not between those
with hip fracture but no depression and controls (p = .12).
This would suggest that the depression and frailty associ-
ation was not a consequence of changes in the cortisol:
DHEAS ratio as a consequence of the hip fracture. Thus,
mediation would appear a more compelling explanation
than confounding.
That cortisol:DHEAS did not mediate all of the associa-
tions between depression and physical function suggests
that other mechanisms also may underlie this relationship,
such as reduced motivation to participate in rehabilitation
or levels of pro-inflammatory cytokines.
This study has several limitations. First, it was primarily
designed to investigate the synergistic effect of what we per-
ceive as depressive symptoms that present post-onset and
potentially as a result of hip fracture on physical function,
through exclusion of patients with a history of depression
pre-fracture prior to age 50 years. However, we do realise
that in the absence of a pre-fracture measure of depressive
symptoms, this is an assumption. Despite excluding those
with a previous diagnosis of depression prior to age 50 years
and those taking anti-depressants, it is possible that some
participants may have had symptoms post-age 50 years but
prior to their hip fracture although none were undergoing
treatment at the time of fracture. Further, our exclusion
of previously depressed patients or those with cognitive
decline, or immune-related comorbidities means our
findings may not be generalisable to the wider hip fracture
population and may have introduced some non-assessable
selection bias in the absence of more general socio-
demographics of patients not being available prior to
informed consent. However, these exclusions do suggest
that the associations reported here would be even stronger
had patients with poorer physical or mental status been
included as these factors are associated with poor recovery
[33]. Third, the sample only included Caucasian patients,
thus further investigation within diverse ethnic groups is
needed. Fourth, the sample comprised mainly women.
However, the ratio of women to men in our sample
reflects the reported sex ratio of hip fractures in the UK.
Fifth, we did not measure pain in our sample, and it is
possible that pain could contribute to both depression and
cortisol levels [34], although individuals with depressiontend to report lower pain levels [35] and our present de-
pressed and non-depressed groups did not differ signifi-
cantly on whether or not they were taking analgesic
medication. Finally, there were a relatively high number of
withdrawals but this is common in studies of hip fracture
in older patients; the rapid changes in setting make it diffi-
cult to track hip fracture patients post-discharge and many
felt too unwell to participate. The sample of patients
included in this group was therefore likely to be in rela-
tively good health compared to those who withdrew. This
highlights that the effect of depression on outcomes is not
restricted to patients with poor health post hip fracture.
Conclusions
In conclusion, depression emerging post-hip fracture in
older adults impairs physical function, including walking
speed, balance, and activities of daily living. This is the
first time that depressive symptoms in the absence of
longer term pre-fracture depression diagnosis have been
shown to relate to recovery and physical frailty. Effects
on walking speed were mediated by alterations in the
cortisol:DHEAS ratio which was heightened among the
depressed group. This novel finding implies that in order
to speed recovery of physical function and independence
following hip fracture, patients should be assessed and
treated for depressive symptoms. This is of relevance to
surgeons and health professionals alike involved in re-
habilitation post-fracture surgery who currently do not
screen this patient group for depressive symptoms. Iden-
tification and treatment of depression in these patients
would improve patient outcomes and quality of life as
well as impacting upon health service costs incurred
through treatment of those with slower recovery and
decreased independence post-fracture. We propose that
correcting the cortisol:DHEAS imbalance by oral supple-
mentation with DHEA may be one means of improving
depressed mood and contributing to better physical
function after hip fracture. However, such an interven-
tion would need to be cautiously informed by the inter-
vention literature in order to determine an effect dosage
and regime for an effect in these patients.
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